Mark Hamstra
ARTICLES BY THIS AUTHOR
- 8/8/2022
Oregon: A pioneer in advancing pharmacy scope
Oregon passed landmark legislation that requires payers to reimburse pharmacists for any clinical services within the state’s pharmacy scope of practice in 2015. - 8/8/2022
Colorado: A framework for protocols
Key developments, including the creation of an infrastructure for statewide protocols in 2016 and a provider status bill, have expanded pharmacists’ scope of practice. - 8/8/2022
State of play: Profiling state efforts to expand pharmacist scope of practice
Pharmacists prove themselves during the pandemic, eye additional authorities. - 8/8/2022
North Dakota: Broad scope in testing capabilities
For many services, pharmacists in the state can bill as a healthcare provider just like physicians. - 3/8/2022
Industry experts offer big ideas
Existing challenges in retail pharmacy are likely to continue, but bold thinking will provide opportunity. - 2/14/2022
Overcoming obstacles: Despite challenges, generics companies optimistic for 2022
Generic drugmakers report making adjustments to their supply chains, including changes in transportation and sourcing strategies, as well as confidence in their outlook for the year ahead. - 1/30/2022
The evolution of retail pharmacy demands innovation: New tools embrace data and automation to drive efficiencies and enhance patient service
Changes in retail pharmacy ushered in by the pandemic will continue to accelerate with greater adoption of technology and clinical care services. - 12/20/2021
CVS Health’s Brenda Lord highlights consumer trends influencing the retail giant’s store-brand portfolio
Drug Store News interviewed Brenda Lord, vice president of private brands and quality assurance at CVS Health, about the retailer’s private-label program. - 12/19/2021
Private labels play leading role for food and drug retailers
Innovative store-brand health-and-wellness products shine during the pandemic and beyond. - 10/27/2021
Seeking reform: DIR fees in the spotlight amid push to rein in drug costs
Pharmacy groups address the implications of direct and indirect remuneration fees on pharmacies and their patients with policymakers.
